View the latest Chairman’s Corner message for our spring edition of Caris Connection. In this issue, you will discover Caris’ latest treatment prediction AI technologies as well as profound insights...
We recently caught up with Dr. Charu Aggarwal, Associate Professor for Lung Cancer Excellence in the Division of Hematology-Oncology at the University of Pennsylvania’s Perelman School of Medicine.
Tune in to hear POA Chairman Chadi Nabhan interview many of today’s leading experts as they discuss the latest developments in the fields of oncology and precision medicine.
ABOUT Huntsman Cancer Institute (HCI) at the University of Utah is the official cancer center of Utah. The cancer campus includes a state-of-the-art cancer specialty hospital as well as two...
Dr. Chadi Nabhan recently caught up with Dr. Charu Aggarwal, Leslye M. Heisler Associate Professor for Lung Cancer Excellence in the Division of Hematology-Oncology at the University of...
Tune in to hear POA Chairman Chadi Nabhan interview many of today’s leading oncology experts as they discuss the latest developments and breakthroughs in the fields of oncology and precision medicine.
Caris Life Sciences® continues to be at the forefront of innovation in molecular science and artificial intelligence (AI) with the recent publications of MI FOLFOXai™ and MI GPSai™. These AI-based, molecular signature prediction tools have advanced personalized medicine by providing more diagnostic insight and overall more effective individualized treatments. These platforms are discussed in more detail here.
As Caris continues to expand its capabilities with the recent launch of new products like MI GPSai™, MI FOLFOXai™ and Whole Exome Sequencing, efforts have been made to expand the laboratory services necessary to support products like these and the platforms behind them. Read more about how Caris is continuing to expand these capabilities, giving even more patients with cancer access to personalized medicine.
Contact Caris Precision Oncology Alliance
If you require additional information on the POA, have questions, comments, or ideas, we’d love to hear from you. Please click on the link below.